Key result
Non-Hispanic Asian adults with hypertension had a lower prevalence of taking antihypertensive medication (63.8%) compared with non-Hispanic white (75.8%) and non-Hispanic black (77.3%) adults.
Cross-Sectional
Absolute Event Rate: 63.8% vs 75.8%
This analysis highlights significant racial, ethnic, and sex disparities in hypertension treatment rates in the United States, identifying non-Hispanic Asian adults as having the lowest treatment prevalence.
Disparities in antihypertensive use merit clinical awareness; leaves open whether targeted efforts can improve rates among non-Hispanic Asian adults.
During 2011-2014, 74.6% of adults aged ≥18 years with hypertension reported taking antihypertensive medication. Overall, a smaller percentage of non-Hispanic Asian adults (63.8%) with hypertension reported taking antihypertensive medication compared with non-Hispanic white (75.8%), non-Hispanic black (77.3%), and Hispanic (70.7%) adults with hypertension. This pattern was found for both men and women with one exception: the difference between non-Hispanic Asian men and Hispanic men was not significant. A larger percentage of non-Hispanic white, non-Hispanic black, and Hispanic women reported taking antihypertensive medication than did their male counterparts.
No takes yet. Share an insight, caveat, or question.
A 2016 study conducted a cross-sectional in Hypertension. Non-Hispanic Asian race/ethnicity vs. Non-Hispanic white, non-Hispanic black, and Hispanic race/ethnicity was evaluated on Self-reported use of antihypertensive medication. Non-Hispanic Asian adults with hypertension had a lower prevalence of taking antihypertensive medication (63.8%) compared with non-Hispanic white (75.8%) and non-Hispanic black (77.3%) adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: